|
|
Prepublished online as a Blood First Edition Paper on March 27, 2003; DOI 10.1182/blood-2002-11-3324.
 Previous Article | Table of Contents | Next Article 
Blood, 15 July 2003, Vol. 102, No. 2, pp. 712-717
RED CELLS
The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation
Wulin Aerbajinai,
Mara Giattina,
Y. Terry Lee,
Mark Raffeld, and
Jeffery L. Miller
From the Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
Transcriptional profiles of cultured primary human erythroid cells were examined to identify those genes involved in the control of erythroid growth during the terminal phase of maturation. Our in silico screening strategy indicated that a hypoxia-inducible proapoptotic member of the Bcl-2 gene family called Nix is expressed during erythropoiesis. We next performed Northern blot analyses and determined that the 1.4-kb Nix transcript is expressed at lower levels in erythroleukemia cells than reticulocytes. Polymerase chain reaction (PCR)–based transcriptional patterning confirmed the increased expression of Nix during human erythropoiesis with a pattern similar to that of Bcl-xL and glycophorin A and opposite that of Bcl-2. Western blot analyses revealed Nix protein levels that were lower than expected due to increased proteosomal degradation. The expression of Nix and Bcl-xL proteins decreased relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) control on the removal of erythropoietin (EPO) from the culture medium. Immunocytochemical analyses demonstrated a similar perinuclear mitochondrial expression pattern for both proteins in hemoglobinized precursors. On the basis of these data, we propose that the proapoptotic factor Nix is a highly regulated effector of growth during terminal erythroid maturation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Kundu, T. Lindsten, C.-Y. Yang, J. Wu, F. Zhao, J. Zhang, M. A. Selak, P. A. Ney, and C. B. Thompson
Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation
Blood,
August 15, 2008;
112(4):
1493 - 1502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Schweers, J. Zhang, M. S. Randall, M. R. Loyd, W. Li, F. C. Dorsey, M. Kundu, J. T. Opferman, J. L. Cleveland, J. L. Miller, et al.
NIX is required for programmed mitochondrial clearance during reticulocyte maturation
PNAS,
December 4, 2007;
104(49):
19500 - 19505.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Goh, M. Josleyn, Y. T. Lee, R. L. Danner, R. B. Gherman, M. C. Cam, and J. L. Miller
The human reticulocyte transcriptome
Physiol Genomics,
July 18, 2007;
30(2):
172 - 178.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Diwan, A. G. Koesters, A. M. Odley, S. Pushkaran, C. P. Baines, B. T. Spike, D. Daria, A. G. Jegga, H. Geiger, B. J. Aronow, et al.
Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis
PNAS,
April 17, 2007;
104(16):
6794 - 6799.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Galvez, E. W. Brunskill, Y. Marreez, B. J. Benner, K. M. Regula, L. A. Kirschenbaum, and G. W. Dorn II
Distinct Pathways Regulate Proapoptotic Nix and BNip3 in Cardiac Stress
J. Biol. Chem.,
January 20, 2006;
281(3):
1442 - 1448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Miller
Erythroid Bcl-xL: better late than never
Blood,
September 1, 2005;
106(5):
1515 - 1516.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ohene-Abuakwa, K. A. Orfali, C. Marius, and S. E. Ball
Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect
Blood,
January 15, 2005;
105(2):
838 - 846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
